Biomarkers and therapeutic targets in giant cell tumor of bone: A comprehensive review
The result's identifiers
Result code in IS VaVaI
<a href="https://www.isvavai.cz/riv?ss=detail&h=RIV%2F00159816%3A_____%2F25%3A00082472" target="_blank" >RIV/00159816:_____/25:00082472 - isvavai.cz</a>
Alternative codes found
RIV/00216224:14310/25:00141796
Result on the web
<a href="https://www.sciencedirect.com/science/article/pii/S8756328225001784?via%3Dihub" target="_blank" >https://www.sciencedirect.com/science/article/pii/S8756328225001784?via%3Dihub</a>
DOI - Digital Object Identifier
<a href="http://dx.doi.org/10.1016/j.bone.2025.117566" target="_blank" >10.1016/j.bone.2025.117566</a>
Alternative languages
Result language
angličtina
Original language name
Biomarkers and therapeutic targets in giant cell tumor of bone: A comprehensive review
Original language description
Giant cell tumor of bone (GCTB) is an intermediate locally aggressive osteolytic tumor with low metastatic potential and a high recurrence rate. It comprises two main types of cells-neoplastic mononuclear stromal cells and osteoclast-like giant cells-which are responsible for the resorption of bone. In addition to surgery, which is the primary treatment of choice, adjuvant therapy is used to lower the risk of recurrence. However, denosumab, the standard adjuvant treatment currently used, only targets osteoclast-like giant cells and does not affect neoplastic stromal cells. Since some GCTBs are inoperable, or even after surgery, there can be residual tumor cells at the site of the tumor, novel therapies, especially those that target neoplastic stromal cells, are needed. Both cell types in GCTB show altered expression of various specific genes and molecules, and these deregulated molecular profiles could serve as biomarkers and targets for targeted therapy. Herein, we summarize the potential biomarkers for both cell types in GCTB and therapeutic agents targeting these molecules with the hope of finding a therapy with improved outcomes and a lower risk of recurrence.
Czech name
—
Czech description
—
Classification
Type
J<sub>imp</sub> - Article in a specialist periodical, which is included in the Web of Science database
CEP classification
—
OECD FORD branch
30211 - Orthopaedics
Result continuities
Project
Result was created during the realization of more than one project. More information in the Projects tab.
Continuities
P - Projekt vyzkumu a vyvoje financovany z verejnych zdroju (s odkazem do CEP)
Others
Publication year
2025
Confidentiality
S - Úplné a pravdivé údaje o projektu nepodléhají ochraně podle zvláštních právních předpisů
Data specific for result type
Name of the periodical
Bone
ISSN
8756-3282
e-ISSN
1873-2763
Volume of the periodical
199
Issue of the periodical within the volume
Oct 2025
Country of publishing house
US - UNITED STATES
Number of pages
14
Pages from-to
117566
UT code for WoS article
001517069900001
EID of the result in the Scopus database
—